Bemcentinib,Pembrolizumab
BerGenBio,Merck
['mesothelioma', 'bemcentinib', 'bergen']
results of mist3 clinical trial will be announced at #asco23 today. led by prof the mist3 trial looked at bergenbio s bemcentinib with prembrolizumab as a treatment for mesothelioma. data will be presented by 
Mesothelioma UK is a national resource centre dedicated to providing specialist Mesothelioma information, support & improved care and treatment